skip to Main Content

News

Latest News, Announcements, and Press Releases

24Nov 20
Codexis And Casdin Capital Launch SynBio Innovation Accelerator

Codexis and Casdin Capital Launch SynBio Innovation Accelerator

REDWOOD CITY, Calif. and NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading Synthetic Biology company developing and supplying differentiated enzyme products for high value markets, in collaboration with leading life science investor Casdin Capital,…
read more
05Nov 20
Codexis Reports Third Quarter 2020 Financial Results

Codexis Reports Third Quarter 2020 Financial Results

Stronger than expected total revenues of $18.4 million delivered in the quarter Higher sequential sales expected again in the fourth quarter, showing growing momentum as we close 2020 Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif.…
read more
06Aug 20
Codexis Adds Dr. Jennifer L. Aaker To Its Board Of Directors

Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker , Ph.D. to its board of directors, expanding membership…
read more
01Aug 20
Codexis Reports Second Quarter 2020 Financial Results

Codexis Reports Second Quarter 2020 Financial Results

Revenues increased 21% to $15 million ; 72% rise in R&D revenue included a significant contribution from the Takeda biotherapeutics partnership Conference call with slides begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search
Search